Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

Stopped early · Phase 2

Conditions studied: Stage IV NSCLC

In brief

This study is for patients with advanced non small cell lung cancer that has progressed despite standard of care. The purpose of the study is to see if Kanglaite injection has any effect on survival.

Key facts

Study ID

NCT01640730

Run by

KangLaiTe USA

People needed

1

Starts

2012-05-01

Expected to finish

2012-10-01

Last updated by the study team

2014-01-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• confirmed (within last 3 months)progressive Stage IV NSCLC
• estimated life span of 3 months
• phase angle of at least 5 as measured by bioimpedance

You may not qualify if…

• currently taking a lipid lowering medications
• has an imminently life threatening condition
• has pre-existing liver disease
• known allergy to soybeans
• uncontrolled diabetes or uncontrolled disturbance of lipid metabolism
• pregnant or lactating
• has a pacemaker or other implantable electronic medical device

Where it is running

• The West Clinic — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.